Abstract
The effect of psyllium hydrophilic mucilloid (PHM) when used as a laxative and/or stool softener on serum cholesterol concentrations was examined in 176 ambulatory elderly participants attending a health screening program. The change in one-year serum cholesterol concentration in subjects using PHM was compared with the change in cholesterol in 741 participants who did not report the use of PHM. Serum cholesterol concentration decreased by 0.073 mmol/liter (2.82 mg/dl) in the treatment group compared with a decrease of 0.036 mmol/liter (1.39 mg/dl) in the control group. After adjusting for confounding factors, excluding psyllium dose, by using a multiple regression model there was no significant difference in the change in serum cholesterol concentration (P=0.935). PHM dosage information was available for 158 participants. After adjusting for baseline serum cholesterol and confounding factors using multiple regression analysis, it was found that the dose of PHM administered was significantly correlated with the change in serum cholesterol (P=0.0120). For every 1-g increase in daily PHM dose there was a 0.022 mmol/liter (0.84 mg/dl) decrease in serum cholesterol concentration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
National Center for Health Statistics: Births, marriages, divorces and deaths for October 1986, in Monthly Vital Statistics Report, Hyattsville, Maryland, Public Health Service, January 23, 1987, vol 35, No. 10, Department of Health and Human Services publication (PHS) 87-1120
Kannel WB, Castelli W, Gorden T: Cholesterol in the prediction of Atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med 90:85–91, 1979
Pooling Project Research Group: Relationship of blood pressure, serum cholesterol, relative weight and ECG abnormalities to the incidence of major coronary events. Final report of the Pooling Project. J Chron Dis 31:201–306, 1978
Stamler J, Wentworth D, Neaton J: Is the relationship between serum cholesterol and risk of death from coronary Heart disease continuous and graded? JAMA 256:2823–2828, 1986
The Lipid Research Clinics Coronary Primary Prevention Trial Results: I Reduction in Incidence in Coronary Heart Disease. JAMA 251:351–364, 1984
The Lipid Research Clinics Coronary Primary Prevention Trials Results: II, The Relationship of Reduction in Incidence of Coronary Heart Disease to Cholesterol Lowering. JAMA 251:365–374, 1984
Rifkin BM, Segal P: Lipid Research Clinics Program reference values for hyperlipidemia. JAMA 250:1869–1872, 1983
Gotto AM Jr, Bierman EL, Conner WE, Ford CH, Frantz ID, Glueck CJ, Grundy SM, Little JA: Recommendations for treatment of hyperlipidemia in adults. Circ 69:1065A-1090A, 1984
Talbert RL: Hyperlipidemia,In Pharmacotherapy: A Pathophysiologic Approach. JT Dipiro, (eds). New York, Elsevier, 1989, pp 300–323
Kinosian BP, Eisenberg JM: Cutting into cholesterol. JAMA 259:2249–2254, 1988
Anderson JW, Zettwoch N, Feldman T, Tietyen-Clark J, Oeltgen P, Bishop CW: Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men. Arch Intern Med 148:292–296, 1988
Hale WE, Marks RG, Stewart RB: The Dunedin Program, a Florida geriatric screening process; design and initial data. J Am Geriatr Soc 27:377–380, 1980
May FE, Stewart RB, Hale WE, Marks RG: Prescribed and non-prescribed drug use in an ambulatory elderly population. South Med J 75:522–527, 1982
Hale WE, Stewart RB, Marks RG: Hematological and biochemical values in the elderly. Age and Ageing 12:275–284, 1983
Allain CC, Poon LS, Chan CSG, Richman W, Fu PC: Enzymatic determination of total serum cholesterol. Clin Chem 20:470–475, 1974
Stein EA: Lipids, Lipoproteins, and Apolipoprotins,In Textbook of Clinical Chemistry. NW Tietz (ed). Philadelphia, WB Saunders, 1986, p 884
Hale WE, Perkins LL, May FE, Marks RG, Stewart RB: Symptom prevalence in the elderly; an evaluation of age, sex, diseases, and medication use. J Am Geriatr Soc 34:333–340, 1986
Anderson JW, Clark JT: Dietary fiber: Hyperlipidemia, hypertension, and coronary heart disease. Am J Gastroenterol 81:907–919, 1986
Bell LP, Hectorne K, Reynolds H, Balm TK, Hunninghake DB: Cholesterol-lowering effects of psyllium hydrophilic mucilloid. JAMA 261:3419–3423, 1989
Pelot D: Screening and Definitive Tests for Malabsorption.In Principles and Practice of Gastroenterology and Hepatology. G Gitnick (ed). New York, Elsevier, 1988, p 637
Author information
Authors and Affiliations
Additional information
Supported in part by a grant from the Procter and Gamble Company and SmithKline Clinical Laboratories.
Rights and permissions
About this article
Cite this article
Stewart, R.B., Hale, W.E., Moore, M.T. et al. Effect of psyllium hydrophilic mucilloid on serum cholesterol in the elderly. Digest Dis Sci 36, 329–334 (1991). https://doi.org/10.1007/BF01318205
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01318205